BOT 0.00% 38.0¢ botanix pharmaceuticals ltd

Ann: Final Sofdra Labelling Discussions with FDA, page-209

  1. 11 Posts.
    lightbulb Created with Sketch. 13
    For a company that has never made a single sale and is about to embark on a revenue stream likely in the 100's of million. I would say a value in the billions is not beyond reason or belief. Maybe you should reconsider your sentiment to hold rather than buy if you alone are the realist.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.